ARCHIVES

Oblimersen Combination Improves CLL Survival

This article is from The Cancer Letter archive.

Vol. 30 No. 12 | December 28, 2007

Download PDF Visit The Full Archive

Related Articles

Univ. Officials Propose Conflict Of Interest Guidelines In Report

April 13, 1990

EntreMed Begins Pilot Phase II Trial Of Small Molecule Angiogenesis Inhibitor.

December 15, 2000

CTEP Publishes Final Version of Plan for Assigning Intellectual Property Rights On Correlative Research

April 8, 2011

In Brief: Jordan To Join MD Anderson Cancer Center

July 25, 2014

RFP Available; Program Announcement

April 16, 1993

AACR Supports Bypass Budget; Public Consortium Sequences Mouse Genome

May 10, 2002